Tulsa Cancer Institute PLLC — Tulsa, Oklahoma

Tulsa Cancer Institute PLLC is a clinical research site located in Tulsa, Oklahoma, United States.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

Tulsa Cancer Institute PLLC has participated in 4 clinical trials.

Therapeutic areas: Pancreatic Cancer, Melanoma, Malignant Melanoma.

Sponsors: Merrimack Pharmaceuticals, Pfizer, Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tulsa

Browse all research sites in Oklahoma · View every site in Tulsa

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Tulsa Cancer Institute PLLC?

Tulsa Cancer Institute PLLC has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Tulsa Cancer Institute PLLC conducted?

Tulsa Cancer Institute PLLC has 4 clinical trials on record. Their work covers Pancreatic Cancer, Melanoma, Malignant Melanoma.

Is Tulsa Cancer Institute PLLC accredited by Crixeo Clinical Trials?

Tulsa Cancer Institute PLLC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Tulsa Cancer Institute PLLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.